TRANSLATE

The mds Hub website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and the mds Hub cannot guarantee the accuracy of translated content. The mds and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.

Now you can support HCPs in making informed decisions for their patients

Your contribution helps us continuously deliver expertly curated content to HCPs worldwide. You will also have the opportunity to make a content suggestion for consideration and receive updates on the impact contributions are making to our content.

Find out more

Do mRNA-based COVID vaccines lead to adverse events in recently transplanted patients?

Featured:

Nil AlbiolNil Albiol

Apr 6, 2022


During the 48th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), the MDS Hub was pleased to speak to Nil Albiol, Hospital de la Santa Creu i Sant Pau, Barcelona, ES. We asked, Do mRNA-based COVID vaccines lead to adverse events in recently transplanted patients?

Do mRNA-based COVID vaccines lead to adverse events in recently transplanted patients?

In this video, Albiol discusses the initial exclusion of transplanted patients from COVID vaccine trials due to the risk of immune-mediated complications. Albiol then comments on the study performed at his center and two other recently published studies, which did not find these side effects in transplanted patients. Finally, Albiol compares the overall results in transplanted patients to the general population.

 

More about...